Telangana’s healthcare schemes are facing a financing crisis that is extending beyond unpaid hospital bills. More than Rs 2,000 crore in Aarogyasri medical dues has reportedly remained pending for between 11 and 15 months, while none of 360 small and medium-sized private hospitals has signed an agreement to join the revamped Employee Health Scheme (EHS). Together, the figures expose a widening gap between the state’s promise of cashless health protection and the financial conditions required to keep hospitals participating.
The immediate problem is not simply that hospitals are waiting for payment. It is that the payment system, package rates and hospital-participation model are shaping which parts of Telangana’s healthcare network remain viable. District-based small and medium hospitals, which are described as the backbone of Aarogyasri and previous employee health schemes, are being asked to deliver treatment at rates they consider unsustainable while carrying operational expenses for months without settlement.
The state government has begun deducting 1.5 per cent of the basic pay of state employees and pensioners to fund the Employee Health Care Trust. Yet the revamped EHS remains largely non-operational because 70 per cent to 80 per cent of small and medium-sized private hospitals, mostly concentrated in districts, have not joined the initiative. The mismatch is significant: funding is being collected from beneficiaries, but the provider network needed to deliver the service has not been secured.
According to Dr. Vaddiraju Rakesh, president of the Telangana Aarogyasri Network Hospitals Association, private hospitals are dealing with Aarogyasri bills exceeding Rs 2,000 crore, accumulated over nearly 15 months, in addition to older EHS dues. The report does not provide a government response to the association’s claims or a payment schedule for clearing the backlog. That leaves the financial position of the scheme dependent on a provider network that says it cannot sustain treatment without timely reimbursement.
The package-rate dispute is at the centre of the disagreement. The report cites a procedure that was earlier reimbursed at Rs 32,100 under Aarogyasri, briefly adjusted to Rs 40,000, and then reduced to Rs 26,500 under the new EHS structure. For smaller hospitals, the reduction is not an isolated pricing issue. It affects whether the reimbursement covers staff salaries, maintenance and other basic operating costs after treatment is delivered.
Dr. Rakesh said the new rates offered no profit margin and that delayed payments extending beyond a year made it difficult for smaller hospitals to participate. The report also states that the state’s present EHS rates are lower than earlier rates for various procedures. Without a detailed cost schedule or an official explanation of how the rates were calculated, it is not possible to establish whether the packages reflect current treatment costs. What is clear from the hospital association’s account is that providers see the rates and payment delays as linked problems rather than separate disputes.
The result is a two-level participation pattern. Top corporate hospitals in Hyderabad have accepted the EHS framework because they are permitted to collect co-payments for room upgrades, additional services and diagnostics. Those arrangements provide an additional revenue stream that is not available to small and medium hospitals operating in districts, according to the report. The contrast suggests that the formal availability of a health scheme does not guarantee equal access across locations or provider types.
This distinction matters because a hospital network is also a spatial network. Corporate hospitals concentrated in Hyderabad may absorb low package rates differently from smaller facilities that serve district populations. If district hospitals do not sign MoUs, beneficiaries may face fewer nearby options even when they remain eligible for treatment under the scheme. The supplied report does not quantify how many patients have been denied treatment, redirected to other hospitals or required to travel farther. It does, however, establish that the provider network is incomplete at the point when employee contributions are being collected.
Aarogyasri and the EHS therefore face a common institutional problem: the state is responsible for designing the entitlement and funding mechanism, while private hospitals are essential to delivering treatment under the schemes. The arrangement only works when three elements remain aligned—package rates that providers can accept, payments that arrive within a workable period, and a geographically adequate network of hospitals. The current figures indicate pressure on all three.
The pending dues also change the meaning of a reimbursement backlog. For a large corporate hospital, delayed public payments may be offset by other revenue streams, including permitted co-payments and private patients. For a small district hospital, the same delay can affect payroll, supplies and routine upkeep. The report specifically says that small and medium providers are unable to carry mounting operational costs without timely payments from the state. In that setting, a delayed claim is not merely an accounting entry; it can influence whether the provider continues accepting scheme patients.
The state’s decision to collect 1.5 per cent of the basic pay of employees and pensioners creates a direct expectation of functioning coverage. Contributions are being made through a defined mechanism, but the report says the scheme remains largely non-operational in much of the small and medium hospital sector. This creates a governance test for the Employee Health Care Trust: the credibility of the fund will depend not only on collections, but also on whether those collections translate into timely payments and a usable network.
The report does not establish the total value of employee contributions, the government’s current cash position, the number of claims pending, or the precise reasons for the payment delays. It also does not include an official statement from the state government or the agencies administering Aarogyasri and the EHS. Those gaps are important because they prevent a full assessment of whether the crisis is primarily a funding shortfall, an administrative bottleneck, a rate-setting dispute, or a combination of all three.
Even with those limitations, the available evidence points to a structural vulnerability in publicly supported healthcare delivery. A scheme can be formally expanded, employee deductions can begin and corporate hospitals can sign agreements, but coverage remains uneven if the district-level providers that supply everyday access cannot participate. The 360 unsigned MoUs offer a concrete measure of that gap, while the Rs 2,000-crore backlog indicates its financial scale.
The next stage will depend on whether the state clears outstanding Aarogyasri and EHS dues, revisits the package rates and brings small and medium hospitals into the new framework. Until those steps are documented, Telangana’s healthcare schemes will continue to carry the appearance of expanded coverage alongside a provider network that remains incomplete where many beneficiaries depend on it.
